Stromová štruktúra MeSH - cefotetán

[d02.065.589.099.249.250.199]

• chemikálie organické [d02] +
  • amidy [d02.065] +
    • laktámy [d02.065.589] +
      • beta-laktámy [d02.065.589.099] +
        • cefalosporíny [d02.065.589.099.249] +
          • cefamycíny [d02.065.589.099.249.250] +
            • cefmetazol [d02.065.589.099.249.250.177]
            • cefotetán [d02.065.589.099.249.250.199]
            • cefoxitín [d02.065.589.099.249.250.222]

[d02.886.665.074.250.199]

• chemikálie organické [d02] +
  • zlúčeniny síry [d02.886] +
    • tiazíny [d02.886.665] +
      • cefalosporíny [d02.886.665.074] +
        • cefamycíny [d02.886.665.074.250] +
          • cefmetazol [d02.886.665.074.250.177]
          • cefotetán [d02.886.665.074.250.199]
          • cefoxitín [d02.886.665.074.250.222]

[d03.383.129.617.235]

• zlúčeniny heterocyklické [d03] +
  • zlúčeniny heterocyklické s 1 jadrom [d03.383] +
    • azoly [d03.383.129] +
      • tetrazoly [d03.383.129.617] +
        • cefotetán [d03.383.129.617.235]
        • cefozopran [d03.383.129.617.264]
        • cilostazol [d03.383.129.617.293]
        • irbesartan [d03.383.129.617.351]
        • losartan [d03.383.129.617.467]
        • olmesartan medoxomil [d03.383.129.617.584] +
        • soli tetrazóliové [d03.383.129.617.700] +
        • valsartan [d03.383.129.617.850] +

[d03.633.100.300.249.250.199]

• zlúčeniny heterocyklické [d03] +
  • zlúčeniny heterocyklické, so spojenými kruhmi [d03.633] +
    • zlúčeniny heterocyklické s 2 jadrami [d03.633.100] +
      • beta-laktámy [d03.633.100.300] +
        • cefalosporíny [d03.633.100.300.249] +
          • cefamycíny [d03.633.100.300.249.250] +
            • cefmetazol [d03.633.100.300.249.250.177]
            • cefotetán [d03.633.100.300.249.250.199]
            • cefoxitín [d03.633.100.300.249.250.222]